Back to ABBV

AbbVie Inc. Accounts Receivable 2015-2026 | ABBV

Beta

What is accounts receivable?

Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.

What is AbbVie Inc.'s current accounts receivable?

AbbVie Inc. (ABBV) annual accounts receivable for 2025 was $12.59B, a 15.29% increase from 2024. AbbVie Inc. accounts receivable for the quarter ending March 31, 2026 was $12.48B.

What was AbbVie Inc.'s accounts receivable in 2024?

AbbVie Inc. annual accounts receivable for 2024 was $10.92B, a 2.12% decline from 2023.

What was AbbVie Inc.'s accounts receivable in 2023?

AbbVie Inc. annual accounts receivable for 2023 was $11.15B, a 0.88% decline from 2022.

What is AbbVie Inc.'s 5-year accounts receivable CAGR?

AbbVie Inc. accounts receivable grew at a compound annual growth rate (CAGR) of 7.37% from FY2020 to FY2025, going from $8.82B to $12.59B over 5 years.

Accounts Receivable History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+7.4%
FY2020
$8.82B
→
FY2025
$12.59B
1516171819202122232425
5 years selected
Accounts Receivable History
PeriodValueChangeSource
FY2025$12.59B+15.3%10-K
FY2024$10.92B-2.1%10-K
FY2023$11.15B-0.9%10-K
FY2022$11.25B+12.8%10-K
FY2021$9.98B+13.1%10-K
FY2020$8.82B+62.5%10-K
FY2019$5.43B+0.8%10-K
FY2018$5.38B+5.8%10-K
FY2017$5.09B+6.9%10-K
FY2016$4.76B+0.6%10-K
FY2015$4.73B-10-K
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →